U.S. COMPANY FILING
BOSTON SCIENTIFIC CORP — Form 10-K filed 2026-02-17
Filing text preview
Boston Scientific reported 2025 net sales of $20.074 billion, up 20% YoY, with GAAP net income of $2.898 billion and adjusted net income of $4.574 billion. The company announced a $14.5 billion acquisition of Penumbra and completed the Nalu Medical acquisition. Intangible asset impairments decreased significantly, while litigation charges increased. The company maintains investment-grade ratings and leverage ratio of 1.92x, in compliance with covenants.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record